Wednesday preview: WA votes in Parliament, Hikma Pharmaceuticals
12th Mar 2019 14:55
(Sharecast News) - Investors may be facing heightened volatility on Wednesday, as financial markets digest the result of Parliament's vote on Theresa May's proposal for the UK's withdrawal agreement with the European Union.
Read moreTobacco stocks rise after FDA boss Gottlieb quits
6th Mar 2019 09:20
(Sharecast News) - Shares in tobacco companies rose on Wednesday after America's chief drug and tobacco regulator unexpectedly resigned overnight.
Read moreHikma launches generic Mitomycin injection in US
29th Jan 2019 09:42
(Sharecast News) - Hikma Pharmaceuticals announced on Tuesday that its Hikma Pharmaceuticals USA division, formerly known as West-Ward Pharmaceuticals, has launched Mitomycin for Injection, USP' at dosages of 20mg and 40mg.
Read moreHikma US launches generic version of Lundbeck's Onfi
10th Dec 2018 14:18
(Sharecast News) - Hikma Pharmaceuticals' US subsidiary has launched a generic equivalent to Lundbeck's Onfi, which is used for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients of two years and older.
Read moreNew management to reinvigorate Smith & Nephew, says Morgan Stanley
10th Dec 2018 13:31
(Sharecast News) - Morgan Stanley upped its stance on Smith & Nephew to 'overweight' from 'equalweight' on Monday, lifting the target price to 1,692p from 1,457p as it argued that new management should help to reinvigorate the top line performance following years of stagnation.
Read moreJefferies downgrades NMC Health, ups Hikma
27th Nov 2018 12:46
(Sharecast News) - Jefferies has adopted a more cautious approach to blue chip NMC Health, cutting its rating to 'underperform' over a range of concerns, including corporate governance.
Read moreTuesday broker round-up
27th Nov 2018 12:26
(Sharecast News) - Pets At Home Group: Liberum downgrades to hold with a target price of 120p.
Read moreHikma in five-year licensing and supply agreement with China's Hansoh
27th Nov 2018 09:59
(Sharecast News) - Hikma Pharmaceuticals has announced a five-year licensing and supply agreement with China's Hansoh Pharmaceutical Group.
Read moreTuesday broker round-up
20th Nov 2018 14:00
(Sharecast News) - Coats: RBC Capital Markets initiates at outperform with a target price of 110p.
Read moreHikma US launches generic version of Pfizer insomnia tablets
19th Nov 2018 10:43
(Sharecast News) - Hikma Pharmaceuticals' US subsidiary has launched a generic equivalent to Pfizer's Halcion tablets for insomnia.
Read moreTuesday broker round-up
30th Oct 2018 13:15
(Sharecast News) - Inmarsat: Numis upgrades to hold with a target price of 430p.
Read morePeel Hunt upgrades Hikma, says upgrade cycle will drive shares
16th Aug 2018 14:17
(Sharecast News) - Peel Hunt upgraded Hikma Pharmaceuticals to 'add' from 'hold' on Thursday and bumped up the price target to 1,950p from 1,160p following the company's "strong" first-half results a day earlier.
Read moreThursday broker round-up
16th Aug 2018 13:09
(Sharecast News) - Esure Group: UBS upgrades to neutral with a target price of 280p.
Read moreGenerics and injectables drive first half growth at Hikma Pharmaceuticals
15th Aug 2018 07:23
(Sharecast News) - Generic drugmaker Hikma Pharmaceuticals issued its interim results for the six months ended 30 June on Wednesday, reporting an 11% improvement in group revenue to $989m, or 10% in constant currency.
Read moreThursday broker round-up
9th Aug 2018 13:02
(Sharecast News) - BBA Aviation: Liberum upgrades to buy with a target price of 370p.
Read more